Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: 4 - What They Never Told You

Shanghai Composite Index Fell 0.4% on Wednesday

Shenzhen Component Index closed down 0.31%

Caixin Global · Aug 28, 2024

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading.

StockNews.com · Aug 14, 2024

3 Blue-Chip Stocks With Strong Buy Ratings

Blue-chip stocks offer stability and consistent growth irrespective of market conditions. Thus, blue chip names Lockheed Martin (LMT), Regeneron Pharmaceuticals (REGN), and Cigna Group (CI) could be prudent additions to your portfolios. These stocks are Strong Buy-rated in our proprietary POWR Ratings system. Read on.

StockNews.com · Aug 14, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

From Ice Baths To Osteopaths: Unproven Therapies At The Olympics

The Paris Olympics have been a showcase not only for athletic prowess but also for therapies such as ice baths and osteopathy which have little scientifically proven medical value, according to experts.

International Business Times · Jul 29, 2024

3 Biotech Stocks With Revolutionary Pipelines to Buy Today

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….

StockNews.com · Jul 29, 2024

Are these the most corporate Olympics ever?

It’s rather exceptional that a G7 Olympic host gets the support of so many of its largest companies.

Fortune · Jul 29, 2024

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

The Conversation · Jun 27, 2024

Read news from The Economist, FT, and more,
with one subscription

The secrets of success with Paul Hudson, CEO of Sanofi

Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.

Fortune · Jun 20, 2024

Usher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to Capitol Hill

Usher will join French pharma giant Sanofi in Washington, D.C., to discuss the importance of early screening for type 1 diabetes.

Fortune · Jun 5, 2024

Sanofi’s CEO thinks OpenAI offers 'insane' potential for the pharmaceutical industry

Sanofi CEO Paul Hudson thinks AI offers 'insane' potential for the pharmaceutical industry, which can spend up to $4 billion developing a drug.

Fortune · May 29, 2024

Sanofi Allies With OpenAI, Formation Bio For AI Use In Drug Development

French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.

International Business Times · May 21, 2024

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

The Guardian - UK · May 11, 2024

Stock Market Today: Stocks End Mixed on the Day, Higher on the Week

The latest consumer sentiment data showed inflation concerns are on the rise.

Kiplinger · May 10, 2024

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios · May 10, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times · May 10, 2024

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

Al Jazeera · May 2, 2024

What is behind the insulin shortage in the US?

Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.

Sanofi To Revamp US Vaccine Operations, Reduce Workforce

Sanofi restructures US vaccine operations to drive growth and maintain competitiveness in the pharmaceutical market.

The Hindu · Apr 4, 2024

Sanofi gets approval for alternative inactivated polio vaccine

Only recently, activists, public health experts, tuberculosis (TB) survivors, and people living with HIV had sought Prime Minister Narendra Modi’s intervention to halt what they said were frequent shortages in the availability of anti-TB drugs.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times · Apr 4, 2024

Sanofi To Settle Around 4,000 Suits Over Zantac Cancer Allegations

Sanofi will settle around 4,000 claims alleging its heartburn medication, Zantac, is linked to cancer.

StockNews.com · Mar 18, 2024

Top 3 Pharma Innovators to Watch Closely

The pharmaceutical industry is experiencing considerable growth, driven by rising healthcare needs, continuous advances in drug discovery & discovery, and M&A activity. So, investors could keep a close eye on top pharma stocks Amneal Pharmaceuticals (AMRX), Collegium Pharmaceutical (COLL), and Sanofi (SNY) for potential gains. Keep reading….

StockNews.com · Feb 28, 2024

Navigate to Success With These 4 Pharma Stocks to Buy

The pharmaceutical industry is expanding due to increased demand for healthcare products and technological advancements. Therefore, fundamentally strong pharma stocks Kamada (KMDA), Hypera (HYPMY), Eli Lilly (LLY) and Sanofi (SNY) might be ideal additions to your portfolio. Read on.

StockNews.com · Feb 27, 2024

4 Sky-Rocketing Pharma Stocks to Watch

The pharmaceutical industry is experiencing significant growth due to the rising demand for quality healthcare and high-quality drugs. This surge is further supported by the rapid growth in the global elderly population and the increase in chronic illnesses. Therefore, investors could consider adding pharma stocks Spero Therapeutics (SPRO), Wave Life…

The Guardian - UK · Feb 22, 2024

The mothers fighting a scandal bigger than thalidomide: ‘We were told the medication was safe’

Since the 1970s, it has been known that sodium valproate can harm babies in the womb. So why was it prescribed to pregnant women?

StockNews.com · Feb 12, 2024

5 Pharma Stocks to Watch With Bullish Momentum

The pharma industry is poised for robust expansion this year with rising demand and technological advancement in the sector. Hence, investors might watch fundamentally solid pharma stocks Procaps Group (PROC), Sanofi (SNY), Viatris (VTRS), Ipsen (IPSEY), and Teva Pharmaceutical Industries (TEVA) for solid gains. Read on.

StockNews.com · Feb 2, 2024

3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

1 … 3 4 5 6

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.